title: Public pressure ends 'bundled' drug program, but how much cost will drop remains unclear.
authors.forename: P
authors.initials: P
authors.lastname: Cotton
mesh_terms: D016363:Antitrust Laws; D003024:Clozapine; D004345:Drug Industry / Q000191:economics* / Q000331:legislation & jurisprudence; D005252:Fees, Pharmaceutical / Q000331:legislation & jurisprudence; D006801:Humans; D037141:Mandatory Programs; D008484:Medicaid / Q000191:economics; D028642:Persons with Psychiatric Disorders; D008991:Monitoring, Physiologic / Q000191:economics; D009518:New York; D012926:Social Control, Formal; D013219:State Government; D014481:United States
chemical_list: D003024:Clozapine